The COL25A1 gene helps nerve cells form and maintain healthy connections with muscles, especially during early development. If this gene does not work properly, some people may be born with weak muscle control, limited eye movement, drooping eyelids, or breathing and feeding problems because certain nerves do not connect as expected. The protein made by this gene helps your cells support motor nerve growth and communication. Variants in this gene are uncommon and are mainly linked to inherited conditions affecting the nerves that control movement.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or regulating activities in the body. Some genes carry the directions for producing proteins, which are the parts of cells that do the work. Other genes mainly help determine when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can visit the LearnHub.
Overview
COL25A1Gene function
What if the gene works
Your nerve cells use the COL25A1 gene to make a collagen protein that helps growing nerves connect with muscles. This supports normal movement by guiding nerve development and steady communication at the nerve-muscle junction.
Risk
What if the gene does not work
Variants in the COL25A1 gene most often cause a congenital condition with limited eye movements and drooping eyelids, sometimes with facial weakness. Milder and more severe variants can affect how early it appears and which features develop.
Treatment
What does that mean for your treatment
No COL25A1-specific treatment or management approach is currently established. Care is symptom based rather than guided by a drug choice linked to the COL25A1 gene. The COL25A1 gene is being studied in early research, including for its possible role in amyloid buildup in Alzheimer disease, but this has not led to guideline-based treatment use.
Conditions associated with COL25A1
Gene function
What if the gene works
Your cells use the COL25A1 gene to build a collagen protein that sits on the cell surface and in the material around cells. This protein is especially active while nerves are growing and linking with muscle. Understanding COL25A1 gene function helps explain how these early connections form in an organized way.
COL25A1 helps build a collagen protein that sits at the cell surface and lines the nearby material around cells. This creates a supportive outer framework that helps cells interact with surrounding tissue.
During development, this protein helps growing nerve fibers extend in the right direction. It supports orderly branching so nerves can reach the right areas within muscle.
COL25A1 supports the formation of neuromuscular junctions (contact points where nerves signal muscles). Well-placed junctions help muscle activity become more coordinated.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can more significantly change how a gene works and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL25A1 gene usually change the protein's shape, stability, or ability to be processed correctly, so less working protein reaches the cell surface. The pattern of how COL25A1 gene variants affect the protein can range from milder changes that partly reduce function to more disruptive variants that greatly weaken or abolish it. In people with disease-causing variants in both copies, the larger the loss of function, the earlier and more marked the eye movement problems may be.
How variants are linked to conditions
Pathogenic variants in the COL25A1 gene cause congenital fibrosis of the extraocular muscles type 5, a rare inherited eye movement condition present from birth. People with this COL25A1 gene condition usually have limited eye movements and often droopy eyelids, and some also have strabismus. Reported cases most often involve two pathogenic variants, one inherited from each parent.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead reflect normal human variation. For many genes, having a variant associated with a condition points to a possible link, not a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn’t yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the COL25A1 gene. For families with a known COL25A1 change, personal risk is shaped mainly by the exact gene change and family history, and a doctor or genetic counselor can help explain what that means.
Inheritance of COL25A1 variants
COL25A1 gene inheritance, for the condition clearly linked to this gene, follows an autosomal recessive pattern. This means a child inherits one altered copy of the COL25A1 gene from each parent. Parents who carry one variant usually do not have the condition themselves. When both parents are carriers, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy.
What does my COL25A1 result mean for my family?
For COL25A1, family implications are usually discussed in the setting of a rare inherited eye movement condition that follows a recessive pattern. This often means parents can be healthy carriers, while brothers and sisters may also be affected or may be carriers. Other close relatives may also carry the variant, especially on the same side of the family. The meaning for relatives depends on the exact COL25A1 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the COL25A1 gene, genetic testing for COL25A1 variants usually uses a blood or saliva sample. A lab reads the gene’s DNA sequence to look for changes, and the result may identify a variant, show no variant was found, or find a change whose health effect is still being clarified.
When should I consider getting a genetic test?
Genetic testing for the COL25A1 gene may be worth considering when someone is born with severe eye movement problems, drooping eyelids, or eyes that do not line up, especially if similar features run in the family. Testing can help confirm whether COL25A1 is the cause and clarify what it may mean for relatives.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how informative it is depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug works well for one person, seems weaker for another, or causes more side effects in someone else. Differences in genes can change how the body breaks down a medicine, moves it through the body, or responds to it at its target, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences affect a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the COL25A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about symptoms, treatment, or side effects are best discussed with your doctor.
History
Interest in the COL25A1 gene grew after researchers studying Alzheimer related brain changes identified a protein fragment called CLAC, short for collagen-like Alzheimer amyloid plaque component. Initially understood through these tissue findings, it was later recognized as coming from the COL25A1 gene. From these first observations, research expanded steadily as scientists clarified its place within the collagen gene family and its activity in the nervous system. Over time, descriptions became more precise, and the gene moved from a little known finding in pathology studies to a recognized part of neurogenetics research. The way this gene was viewed has shifted over time, especially as its links to brain development and inherited neuromuscular conditions became clearer.